However, SPARC knockdown by both shRNAs significantly reduced pancreatic cancer cell migration in wound scratch assays and their invasive properties, as measured by in vitro Boyden assays (Figures 6E–6G and S7). The gene discussed is SPARC; the disease is familial pancreatic carcinoma.